Who Buys Dapagliflozin from India — 502 Importers Behind a $49.5M Market
India's dapagliflozin import market is served by 502 active buyers who collectively imported $49.5M across 5,104 shipments. AWAMEDICA (IRAQ) leads with a 10.0% market share, followed by GROUPE AFFI and MYLAN IRELAND LTD. The top 5 buyers together control 29.6% of total import value, reflecting a moderately competitive buyer landscape.
Dapagliflozin buyer data — 502 importers · $49.5M market · 5,104 shipmentsTransData Nexus · Indian Customs Data
Top Dapagliflozin Importers — Ranked by Import Value
AWAMEDICA (IRAQ) is the leading dapagliflozin importer from India, holding a 10.0% share of the $49.5M market across 5,104 shipments from 502 buyers. The top 5 buyers — AWAMEDICA (IRAQ), GROUPE AFFI (CANADA), MYLAN IRELAND LTD (NETHERLANDS), JAMP PHARMA CORPORATION (CANADA), SINO UNIVERSAL PHARMACEUTICAL CO (CHINA) — collectively control 29.6% of total import value.
Top Dapagliflozin Buyers & Importers
Ranked by import value · 502 active buyers · Indian Customs (DGFT) data
May 2026
Top Dapagliflozin Buyers & Importers — Ranked by Import Value. 502 active buyers with import value, shipments, country and supplier data compiled from Indian Customs records by TransData Nexus.
Which companies are buying Dapagliflozin — and from which countries?
Flow of Dapagliflozin exports from India: each country's share and the named importers behind the numbers
Dapagliflozin — Buyer Countries to Key Importers
Trade flow: top importing countries → named buyer companies
Top 5 importing countries account for 58.6% of global Dapagliflozin imports — led by Canada (25.9%) with a total trade value of $49.5M across 5,104 shipments from India.
Market Analysis: Top Importing Countries & Their Importers
1Canada
Canada emerges as the first largest importing country, achieving a total trade value of $12.8M through 228 shipments. This represents a market share of 25.9% of the total market activity, demonstrating their significant presence in the industry.
Top Importers: Canada has a diverse importer base, with their top importers including:
• GROUPE AFFI - $3.5M (27.0% of country's total business)
• JAMP PHARMA CORPORATION - $2.3M (17.8% of country's total business)
• AURO PHARMA INC - $1.3M (10.4% of country's total business)
• JAMP PHARMA CORPORATION. - $860.5K (6.7% of country's total business)
• MANTRA DISTRIBUTIONS INC - $850.9K (6.6% of country's total business)
• Rest of Canada's importers - $4.0M (31.4% of country's total business)
Key Insight: Canada demonstrates strong market positioning with an average shipment value of $56.2K, indicating premium pricing strategy compared to the market average of $9.7K.
Canada is a key market for Dapagliflozin imports, representing 25.9% of total trade value.
The 502 buyers of Dapagliflozin from India can be categorized into several segments:
Distributors: Entities like GROUPE AFFI (Canada) and JAMP PHARMA CORPORATION (Canada) function as intermediaries, purchasing Dapagliflozin in bulk and supplying it to pharmacies, hospitals, and clinics. Their buying behavior typically involves large, regular orders to maintain a steady supply chain.
Contract Manufacturers: Companies such as MYLAN IRELAND LTD (Netherlands) and AURO PHARMA INC (Canada) procure Dapagliflozin as an active pharmaceutical ingredient (API) for the production of finished dosage forms. Their procurement patterns are aligned with production schedules and market demand forecasts.
Re-exporters: Firms like REGENCY PHARMA LIMITED (Mauritius) and JONAR TRANSPORT (Iceland) import Dapagliflozin with the intent to export it to other markets. Their purchasing behavior is influenced by global demand fluctuations and regulatory environments in target export destinations.
Government Procurement Agencies: Entities such as AWAMEDICA (Iraq) and AWAMEDICA PESHAWA STREET (Iraq) likely engage in procurement for public health initiatives, including national tenders. Their buying patterns are characterized by large-volume purchases, often through competitive bidding processes, to meet public health needs.
For the top five importing countries, the import regulations for Dapagliflozin are as follows:
Canada:
Regulatory Authority: Health Canada.
Import Registration Process: Importers must obtain a Drug Establishment License (DEL) and ensure the product is listed on Health Canada's Drug Product Database. Exceptional importation is permitted under specific conditions, such as drug shortages, as outlined in the Food and Drug Regulations.
Estimated Timeline for Registration: The standard review process for a New Drug Submission (NDS) is approximately 300 days.
Import Tariff/Duty for HS 30049099: Pharmaceutical products under this HS code are typically duty-free in Canada.
The demand for Dapagliflozin in importing countries is driven by several factors:
Disease Prevalence: The rising incidence of type 2 diabetes globally has increased the need for effective treatments like Dapagliflozin. For instance, the International Diabetes Federation reported in 2025 that approximately 537 million adults worldwide were living with diabetes, a significant increase from previous years.
Government Healthcare Programs: Many countries have implemented national health programs aimed at managing chronic diseases, including diabetes. These programs often subsidize medications, making them more accessible to the population.
Universal Health Coverage Expansion: Efforts to achieve universal health coverage have led to increased inclusion of essential medicines in national formularies, thereby boosting demand.
WHO Essential Medicines List Procurement: Inclusion of Dapagliflozin in the WHO Essential Medicines List encourages countries to procure it for their public health systems, ensuring wider availability.
Common Questions — Dapagliflozin Buyers & Importers
Answers based on Indian Customs (DGFT) shipment records compiled by TransData Nexus
QWho is the largest dapagliflozin buyer importing from India?
Based on import volume and value, AWAMEDICA (IRAQ) leads with $5.0M in imports and a 10.0% market share — the highest of any single dapagliflozin importer. GROUPE AFFI (CANADA) and MYLAN IRELAND LTD (NETHERLANDS) are the next largest buyers.
QHow many companies buy dapagliflozin from India?
There are 502 active dapagliflozin buyers importing from India, with a combined market of $49.5M across 5,104 shipments to 113 countries. The top 5 buyers hold 29.6% of total import value, while the remaining 497 buyers handle the other 70.4%.
QWhich countries import the most dapagliflozin from India?
The top importing countries for dapagliflozin from India are Canada (25.9%), Iraq (17.2%), China (5.6%), Netherlands (5.0%), Philippines (4.8%). These markets represent the largest demand centres for Indian pharmaceutical exports of dapagliflozin, with buyers ranging from government procurement agencies to private pharmaceutical distributors.
QWhat is the average import order value for dapagliflozin from India?
The average import transaction value for dapagliflozin from India is $9.7K, with an average unit price of . Order sizes vary significantly based on buyer type — government tenders tend to be larger while private distributors place more frequent smaller orders.
The 502 buyers of Dapagliflozin from India can be categorized into several segments:
Distributors: Entities like GROUPE AFFI (Canada) and JAMP PHARMA CORPORATION (Canada) function as intermediaries, purchasing Dapagliflozin in bulk and supplying it to pharmacies, hospitals, and clinics. Their buying behavior typically involves large, regular orders to maintain a steady supply chain.
Contract Manufacturers: Companies such as MYLAN IRELAND LTD (Netherlands) and AURO PHARMA INC (Canada) procure Dapagliflozin as an active pharmaceutical ingredient (API) for the production of finished dosage forms. Their procurement patterns are aligned with production schedules and market demand forecasts.
Re-exporters: Firms like REGENCY PHARMA LIMITED (Mauritius) and JONAR TRANSPORT (Iceland) import Dapagliflozin with the intent to export it to other markets. Their purchasing behavior is influenced by global demand fluctuations and regulatory environments in target export destinations.
Government Procurement Agencies: Entities such as AWAMEDICA (Iraq) and AWAMEDICA PESHAWA STREET (Iraq) likely engage in procurement for public health initiatives, including national tenders. Their buying patterns are characterized by large-volume purchases, often through competitive bidding processes, to meet public health needs.
For the top five importing countries, the import regulations for Dapagliflozin are as follows:
Canada:
Regulatory Authority: Health Canada.
Import Registration Process: Importers must obtain a Drug Establishment License (DEL) and ensure the product is listed on Health Canada's Drug Product Database. Exceptional importation is permitted under specific conditions, such as drug shortages, as outlined in the Food and Drug Regulations.
Estimated Timeline for Registration: The standard review process for a New Drug Submission (NDS) is approximately 300 days.
Import Tariff/Duty for HS 30049099: Pharmaceutical products under this HS code are typically duty-free in Canada.
The demand for Dapagliflozin in importing countries is driven by several factors:
Disease Prevalence: The rising incidence of type 2 diabetes globally has increased the need for effective treatments like Dapagliflozin. For instance, the International Diabetes Federation reported in 2025 that approximately 537 million adults worldwide were living with diabetes, a significant increase from previous years.
Government Healthcare Programs: Many countries have implemented national health programs aimed at managing chronic diseases, including diabetes. These programs often subsidize medications, making them more accessible to the population.
Universal Health Coverage Expansion: Efforts to achieve universal health coverage have led to increased inclusion of essential medicines in national formularies, thereby boosting demand.
WHO Essential Medicines List Procurement: Inclusion of Dapagliflozin in the WHO Essential Medicines List encourages countries to procure it for their public health systems, ensuring wider availability.
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
2Iraq
Iraq emerges as the second largest importing country, achieving a total trade value of $8.5M through 79 shipments. This represents a market share of 17.2% of the total market activity, demonstrating their significant presence in the industry.
Top Importers: Iraq has a diverse importer base, with their top importers including:
• AWAMEDICA - $5.0M (58.1% of country's total business)
• AWAMEDICA PESHAWA STREET - $1.4M (15.8% of country's total business)
• AYSA DENIZCILIK TIC. TUR. VE SAN. A - $846.5K (9.9% of country's total business)
• ROZ LOJISTIK ULUSLARARASI TASIMACIL - $791.8K (9.3% of country's total business)
Key Insight: Iraq demonstrates strong market positioning with an average shipment value of $108.0K, indicating premium pricing strategy compared to the market average of $9.7K.
Iraq is a key market for Dapagliflozin imports, representing 17.2% of total trade value.
Primary Market
Secondary Market
3China
China emerges as the third largest importing country, achieving a total trade value of $2.8M through 19 shipments. This represents a market share of 5.6% of the total market activity, demonstrating their significant presence in the industry.
Top Importers: China has a diverse importer base, with their top importers including:
• SINO UNIVERSAL PHARMACEUTICAL CO - $1.4M (52.3% of country's total business)
Key Insight: China demonstrates strong market positioning with an average shipment value of $145.2K, indicating premium pricing strategy compared to the market average of $9.7K.
China is a key market for Dapagliflozin imports, representing 5.6% of total trade value.
Primary Market
Secondary Market
4Netherlands
Netherlands emerges as the fourth largest importing country, achieving a total trade value of $2.5M through 10 shipments. This represents a market share of 5.0% of the total market activity, demonstrating their significant presence in the industry.
Top Importers: Netherlands has a diverse importer base, with their top importers including:
• MYLAN IRELAND LTD - $2.5M (100.0% of country's total business)
Key Insight: Netherlands demonstrates strong market positioning with an average shipment value of $249.7K, indicating premium pricing strategy compared to the market average of $9.7K.
Netherlands is a key market for Dapagliflozin imports, representing 5.0% of total trade value.
Primary Market
Secondary Market
5Philippines
Philippines emerges as the fifth largest importing country, achieving a total trade value of $2.4M through 4 shipments. This represents a market share of 4.8% of the total market activity, demonstrating their significant presence in the industry.
Top Importers: Philippines has a diverse importer base, with their top importers including:
• UNILAB, INC. - $581.8K (24.5% of country's total business)
Key Insight: Philippines demonstrates strong market positioning with an average shipment value of $593.7K, indicating premium pricing strategy compared to the market average of $9.7K.
Philippines is a key market for Dapagliflozin imports, representing 4.8% of total trade value.
Primary Market
Secondary Market
Understanding these segments is crucial for tailoring marketing strategies and supply chain logistics to meet the specific needs and behaviors of each buyer type.
TransData Nexus Research · Government and regulatory sourcesMar 2026
Import Registration Process: Importers must register pharmaceutical products with the State Company for Marketing Drugs and Medical Appliances (Kimadia), providing comprehensive documentation including product dossiers and certificates of analysis.
Estimated Timeline for Registration: The registration process can take between 6 to 12 months, depending on the completeness of the application and regulatory workload.
Import Tariff/Duty for HS 30049099: Pharmaceutical imports are generally subject to a 5% customs duty, though exemptions may apply for essential medicines.
China:
Regulatory Authority: National Medical Products Administration (NMPA).
Import Registration Process: Foreign manufacturers must obtain a Drug Import License and register the product with the NMPA, which includes submitting clinical trial data and undergoing a Good Manufacturing Practice (GMP) inspection.
Estimated Timeline for Registration: The process typically takes 12 to 18 months.
Import Tariff/Duty for HS 30049099: Pharmaceutical products under this HS code are subject to a 4% import duty, with potential reductions under specific trade agreements.
Import Registration Process: Importers must ensure the product has a valid marketing authorization from the MEB. Mutual recognition procedures within the EU can expedite this process if the product is already authorized in another EU member state.
Estimated Timeline for Registration: Approximately 210 days under the decentralized procedure.
Import Tariff/Duty for HS 30049099: As part of the EU, the Netherlands applies a 0% import duty on pharmaceutical products under this HS code.
Philippines:
Regulatory Authority: Food and Drug Administration Philippines (FDA Philippines).
Import Registration Process: Importers must secure a Certificate of Product Registration (CPR) from the FDA Philippines, which involves submitting product dossiers, GMP certificates, and samples for evaluation.
Estimated Timeline for Registration: The registration process can take 6 to 12 months.
Import Tariff/Duty for HS 30049099: Pharmaceutical products under this HS code are generally subject to a 3% import duty, with possible exemptions for essential medicines.
Compliance with these regulations is essential for market entry and sustained operations in these countries.
TransData Nexus Research · Government and regulatory sourcesMar 2026
Tender-Based Purchasing: Government and large healthcare providers often use tendering processes to procure medications, leading to bulk purchases and stable demand.
With 502 buyers across 113 countries, the market for Dapagliflozin is robust, reflecting its critical role in diabetes management and the global commitment to improving healthcare outcomes.
TransData Nexus Research · Government and regulatory sourcesMar 2026
$11.25 per unit
Understanding these segments is crucial for tailoring marketing strategies and supply chain logistics to meet the specific needs and behaviors of each buyer type.
TransData Nexus Research · Government and regulatory sourcesMar 2026
Import Registration Process: Importers must register pharmaceutical products with the State Company for Marketing Drugs and Medical Appliances (Kimadia), providing comprehensive documentation including product dossiers and certificates of analysis.
Estimated Timeline for Registration: The registration process can take between 6 to 12 months, depending on the completeness of the application and regulatory workload.
Import Tariff/Duty for HS 30049099: Pharmaceutical imports are generally subject to a 5% customs duty, though exemptions may apply for essential medicines.
China:
Regulatory Authority: National Medical Products Administration (NMPA).
Import Registration Process: Foreign manufacturers must obtain a Drug Import License and register the product with the NMPA, which includes submitting clinical trial data and undergoing a Good Manufacturing Practice (GMP) inspection.
Estimated Timeline for Registration: The process typically takes 12 to 18 months.
Import Tariff/Duty for HS 30049099: Pharmaceutical products under this HS code are subject to a 4% import duty, with potential reductions under specific trade agreements.
Import Registration Process: Importers must ensure the product has a valid marketing authorization from the MEB. Mutual recognition procedures within the EU can expedite this process if the product is already authorized in another EU member state.
Estimated Timeline for Registration: Approximately 210 days under the decentralized procedure.
Import Tariff/Duty for HS 30049099: As part of the EU, the Netherlands applies a 0% import duty on pharmaceutical products under this HS code.
Philippines:
Regulatory Authority: Food and Drug Administration Philippines (FDA Philippines).
Import Registration Process: Importers must secure a Certificate of Product Registration (CPR) from the FDA Philippines, which involves submitting product dossiers, GMP certificates, and samples for evaluation.
Estimated Timeline for Registration: The registration process can take 6 to 12 months.
Import Tariff/Duty for HS 30049099: Pharmaceutical products under this HS code are generally subject to a 3% import duty, with possible exemptions for essential medicines.
Compliance with these regulations is essential for market entry and sustained operations in these countries.
TransData Nexus Research · Government and regulatory sourcesMar 2026
Tender-Based Purchasing: Government and large healthcare providers often use tendering processes to procure medications, leading to bulk purchases and stable demand.
With 502 buyers across 113 countries, the market for Dapagliflozin is robust, reflecting its critical role in diabetes management and the global commitment to improving healthcare outcomes.
TransData Nexus Research · Government and regulatory sourcesMar 2026
Analysis Methodology
1.Buyer Identification: 502 global importers of Dapagliflozin identified from consignee fields in DGFT shipping bill records.
2.Import Value Analysis: Total import value aggregated from 5,104 individual shipping bill records. Values are FOB in USD.
3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation.
4.Geographic Distribution: Buyer imports distributed across 113 destination countries with market share per buyer calculated from capped values.
